TGFB1 and neoplasm: Regulatory B cells (Bregs) in the myeloma microenvironment facilitate immune tolerance by secreting transforming growth factor-β (TGF-β), interleukin-10 (IL-10), and interleukin-35 (IL-35), suppressing anti-tumor immune responses [20,21,22].